Question 1

What is the catalog number for CCDC13 Over-expression Lysate Product?

Accepted Answer

The catalog number for CCDC13 Over-expression Lysate Product is GWB-9A8524.

Question 2

What sizes are available for CCDC13 Over-expression Lysate Product?

Accepted Answer

CCDC13 Over-expression Lysate Product is available in the following size(s): 0.1 mg.

Question 3

Is CCDC13 Over-expression Lysate Product in stock?

Accepted Answer

CCDC13 Over-expression Lysate Product is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

Question 5

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

CCDC13 Over-expression Lysate Product

Product Specifications

Frequently Asked Questions

Explore Other Products

Recombinant HIV-1 gp140 Protein (group M, subtype CRF07_BC) (His Tag)

IRF6 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2C10]

Sf3b3 (NM_133953) Mouse Recombinant Protein

Phospho-V-Myb+C-Myb (S11) Recombinant Rabbit Monoclonal Antibody [SZ04-81]

TGM6 Rabbit Polyclonal Antibody

Ccdc141 Mouse Gene Knockout Kit (CRISPR)